The New England Journal of Medicine is a leading medical journal providing research, reviews, and commentary on clinical practice and biomedical science.

2024年6月8日 · Metabolic dysfunction–associated steatohepatitis (MASH) is a progressive liver disease associated with liver-related complications and death. The efficacy and safety of …

2024年5月24日 · Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with semaglutide would …

2023年12月20日 · The editors announce a new Perspective series exploring key ethical questions facing medicine today; the hope is that medical ethics can keep pace with the evolution — and …

2024年7月31日 · Parkinson’s disease is a multisystem neurodegenerative disorder with motor and prominent, sometimes premonitory, nonmotor symptoms. Detection of gene variants may …

2024年5月15日 · Increased global temperature is associated with a wide range of health risks, which are disproportionately high for certain populations. Individual- and population-level …

2021年2月10日 · Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg …

2020年12月10日 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a …

2024年7月17日 · Insomnia is common and frequently occurs with other disorders. First-line cognitive behavioral therapy with or without medication can produce rapid, sustained …

The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on biomedical science and clinical practice.